Trial NCT04796922

View at ClinicalTrials.gov 
Org. Study IDs: INCB 50465-302

Last trial update was posted on 2022-07-18

MeSH Interventions

Obinutuzumab Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular

Other Conditions

Follicular Lymphoma ( FL) Marginal Zone Lymphoma (MZL)

Stopping Reasons

This study was withdrawn due to a business decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID